• Issue

    Inflammatory Bowel Diseases: Volume 17, Issue 4

    875-1061
    April 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Basic Science Articles

Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides†

Amosy E. M'Koma MD, PhD,  Erin H. Seeley PhD,  Mary K. Washington MD, PhD,  David A. Schwartz MD,  Roberta L. Muldoon MD,  Alan J. Herline MD,  Paul E. Wise MD,  Richard M. Caprioli PhD, 
  • Pages: 875-883
  • First Published: 30 August 2010

New therapeutic targets in ulcerative colitis: The importance of ion transporters in the human colon

Klaudia Farkas MD,  Sunil Yeruva MSc, PhD,  Zoltán Rakonczay Jr MD, PhD,  Lisa Ludolph MSc,  Tamás Molnár MD, PhD,  Ferenc Nagy MD, PhD,  Zoltán Szepes MD, PhD,  Andrea Schnúr MSc,  Tibor Wittmann MD, PhD,  Jessica Hubricht MD,  Brigitte Riederer MSc, PhD,  Viktória Venglovecz MSc, PhD,  György Lázár MD, PhD,  Marianna Király MSc,  Ákos Zsembery MD, PhD,  Gábor Varga MSc, PhD, DSc,  Ursula Seidler XX,  Péter Hegyi MD, PhD, 
  • Pages: 884-898
  • First Published: 18 August 2010

Neonatal exposure to fecal antigens reduces intestinal inflammation

Beate C. Sydora PhD,  Sarah M. McFarlane,  Jason S. G. Doyle MD,  Richard N. Fedorak MD, 
  • Pages: 899-906
  • First Published: 07 September 2010

Cytokine regulation of OCTN2 expression and activity in small and large intestine

Mikihiro Fujiya MD, PhD,  Yuhei Inaba MD, PhD,  Mark W. Musch PhD,  Shien Hu MD,  Yutaka Kohgo MD, PhD,  Eugene B. Chang MD, 
  • Pages: 907-916
  • First Published: 18 August 2010

Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis

Nabeetha A. Nagalingam MPhil,  John Y. Kao MD,  Vincent B. Young MD, PhD, 
  • Pages: 917-926
  • First Published: 08 November 2010

Functional analysis of agalactosyl IgG in inflammatory bowel disease patients

Sachiko Nakajima MD,  Hideki Iijima MD, PhD,  Shinichiro Shinzaki MD, PhD,  Satoshi Egawa MD, PhD,  Takahiro Inoue MD,  Akira Mukai MD,  Yoshito Hayashi MD,  Jumpei Kondo MD,  Tomofumi Akasaka MD,  Tsutomu Nishida MD, PhD,  Tatsuya Kanto MD, PhD,  Eiichi Morii MD, PhD,  Tsunekazu Mizushima MD, PhD,  Eiji Miyoshi MD, PhD,  Masahiko Tsujii MD, PhD,  Norio Hayashi MD, PhD, 
  • Pages: 927-936
  • First Published: 07 September 2010

Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case–control study

Vibeke Andersen PhD,  Elaine Nimmo PhD,  Henrik B. Krarup PhD,  Hazel Drummond BSc,  Jane Christensen MSc,  Gwo-tzer Ho PhD,  Mette Østergaard PhD,  Anja Ernst PhD,  Charlie Lees Prof,  Bent A. Jacobsen PhD,  Jack Satsangi Prof,  Ulla Vogel Prof, 
  • Pages: 937-946
  • First Published: 27 August 2010

Original Clinical Articles

Endoscopic monitoring of infliximab therapy in Crohn's disease†

Clas-Göran af Björkesten MD,  Urpo Nieminen MD, PhD,  Ulla Turunen MD,  Perttu E. Arkkila MD, PhD,  Taina Sipponen MD, PhD,  Martti A. Färkkilä MD, PhD, 
  • Pages: 947-953
  • First Published: 21 September 2010

Immediate and long-term outcomes of corticosteroid therapy in pediatric crohn's disease patients

Alfreda Krupoves MD,  David R. Mack MD,  Ernest G. Seidman MD,  Colette Deslandres MD,  Vytautas Bucionis MD,  Devendra K. Amre PhD, 
  • Pages: 954-962
  • First Published: 09 March 2011

Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease

Konstantinos A. Oikonomou MD,  Andreas N. Kapsoritakis MD, PhD,  Anastasia I. Kapsoritaki MD, PhD,  Anastassios C. Manolakis MD, PhD,  Elisavet K. Tiaka MD,  Fotios D. Tsiopoulos MD,  Ilias A. Tsiompanidis MD, PhD,  Spiros P. Potamianos MD, PhD, 
  • Pages: 963-970
  • First Published: 09 March 2011

Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease

Eugeni Domènech M.D., Ph.D.,  Sílvia Carrión M.D.,  Esther Garcia-Planella M.D.,  Míriam Mañosa M.D.,  Jordi Gordillo M.D.,  Mar Concepción M.D.,  Carlos Guarner M.D., Ph.D.,  Eduard Cabré M.D., Ph.D., 
  • Pages: 971-975
  • First Published: 07 September 2010

Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease†‡

Ashwin N. Ananthakrishnan MD, MPH,  Emily L. McGinley MS, MPH,  Kia Saeian MD, MSc, Epi,  David G. Binion MD, 
  • Pages: 976-983
  • First Published: 07 September 2010

Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis

Magaly Zappa MD,  Carmen Stefanescu MD,  Dominique Cazals-Hatem MD,  Frédéric Bretagnol MD,  Lydia Deschamps MD,  Alain Attar MD,  Béatrice Larroque MD,  Xavier Tréton MD,  Yves Panis MD,  Valérie Vilgrain MD,  Yoram Bouhnik MD, 
  • Pages: 984-993
  • First Published: 18 August 2010

Irritable pouch syndrome is characterized by visceral hypersensitivity

Bo Shen MD,  Claudia Sanmiguel MD,  Ana E. Bennett MD,  Lei Lian MD, PhD,  Brett Larive MS,  Feza H. Remzi MD,  Victor W. Fazio MB, MS,  Edy E. Soffer MD, 
  • Pages: 994-1002
  • First Published: 09 March 2011

Different clinical characteristics in hispanic and non-hispanic whites with ileal pouch–anal anastomosis: A case–control study†

Lei Lian MD,  Lauren Moore BA,  Xiao-Jian Wu MD, PhD,  Xiao-Sheng He MD,  Ping Lan MD, PhD,  Bo Shen MD, 
  • Pages: 1003-1007
  • First Published: 18 August 2010

Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity

Miguel Regueiro MD,  Joseph Rodemann MD,  Kevin E. Kip PhD,  Melissa Saul MS,  Jason Swoger MD,  Leonard Baidoo MD,  Marc Schwartz MD,  Arthur Barrie MD, PhD,  David Binion MD, 
  • Pages: 1008-1014
  • First Published: 01 September 2010

Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: A population-based study†

Fernando Fernández-Bañares MD PhD,  Antonio Salas MD, PhD,  Maria Esteve MD, PhD,  Laura Pardo MD,  Jaume Casalots MD,  Montserrat Forné MD, PhD,  Jorge C. Espinós MD,  Carme Loras MD,  Merce Rosinach MD,  Josep M. Viver MD, PhD, 
  • Pages: 1015-1020
  • First Published: 27 September 2010

Basic Science Reviews

Using metabolomic analysis to understand inflammatory bowel diseases

Hui-Ming Lin PhD,  Nuala A. Helsby PhD,  Daryl D. Rowan PhD,  Lynnette R. Ferguson PhD, 
  • Pages: 1021-1029
  • First Published: 09 March 2011

Role of sensory neurons in colitis: increasing evidence for a neuroimmune link in the gut

Matthias A. Engel MD,  Christoph Becker MD, PhD,  Peter W. Reeh MD, PhD,  Markus F. Neurath MD, PhD, 
  • Pages: 1030-1033
  • First Published: 18 August 2010

Clinical Review

Renal manifestations and complications of inflammatory bowel disease

Konstantinos Oikonomou MD,  Andreas Kapsoritakis MD, PhD,  Theodoros Eleftheriadis MD, PhD,  Ioannis Stefanidis MD, PhD,  Spiros Potamianos MD, PhD, 
  • Pages: 1034-1045
  • First Published: 14 September 2010

Selected Summaries

Sew or staple: Does it make a difference?

Madhulika G. Varma MD, 
  • Pages: 1046-1047
  • First Published: 04 November 2010

Incidence in pediatric IBD is rising: Help from health administrative data

Salvatore Cucchiara MD, PhD,  Laura Stronati PhD, 
  • Pages: 1048-1049
  • First Published: 04 November 2010

Letters to the Editor

Ulcerative colitis triggered by pegylated interferon alone therapy for chronic hepatitis C

Akif Altınbas MD,  Fulya Koybasıoglu MD,  Elif Aktas MD,  Barıs Yılmaz MD,  Sahin Coban MD, 
  • Page: 1050
  • First Published: 09 March 2011

Differential analysis of Crohn's disease and ulcerative colitis by mass spectrometry

Anja Freiwald Dipl.-Ing,  Lei Mao MD,  Vitam Kodelja MD,  Magdalena Kliem Dipl.-Ing,  Dörthe Schuldt MD,  Stefan Schreiber PhD,  Andre Franke PhD,  Sascha Sauer MD, 
  • Pages: 1051-1052
  • First Published: 09 March 2011

Severe adrenal insufficiency complicating budesonide therapy for Crohn's disease

Charles Berkelhammer MD,  Mais Trabolsi MD,  Jelena Andrejic MD,  Tahira Yasmeen MD, 
  • Pages: 1053-1054
  • First Published: 09 March 2011

RIP2 polymorphisms in inflammatory bowel diseases†

R. Thiébaut,  V. Douchin PhD,  C. Jung MD,  F. Merlin,  J.F. Colombel MD, PhD,  M. Lemann MD, PhD,  S. Almer MD, PhD,  C. Tysk MD, PhD,  C. O'Morain MD, PhD,  M. Gassull MD, PhD,  Y. Finkel MD, PhD,  H. Zouali PhD,  L. Pascoe PhD,  J.P. Hugot MD, PhD, 
  • Page: 1055
  • First Published: 09 March 2011

Metastatic Crohn's disease of the penis in a pediatric patient

John F. Pohl MD,  Jessica M. Comstock MD,  Siam Oottamasathien MD, 
  • Page: 1056
  • First Published: 09 March 2011

Role of PPARG gene variants in inflammatory bowel disease

Jürgen Glas MD, MSc,  Julia Seiderer MD,  Christian Markus MD,  Simone Pfennig,  Martin Wetzke MD,  Ekaterini Paschos DMD,  Burkhard Göke MD,  Thomas Ochsenkühn MD,  Bertram Müller-Myhsok MD,  Julia Diegelmann PhD,  Darina Roeske PhD,  Stephan Brand MD, 
  • Pages: 1057-1058
  • First Published: 18 August 2010

Crohn's disease: Ingested matter matters

Gergor Bartel MD, PhD,  Ilse Weiss BSc,  Christoph Gasche MD, 
  • Page: 1059
  • First Published: 18 August 2010

Multiple and fulminant cutaneous squamous cell carcinomas in a Crohn's disease patient treated with immunosuppressants and adalimumab

S. Nancey MD, PhD,  G. Boschetti MD,  E. Cotte MD,  A. Cathey-Javouhay MD,  M. Laidet MD,  A. Chichery MD,  Y. Francois MD,  O. Glehen MD, PhD,  B. Flourié MD, PhD, 
  • Pages: 1060-1061
  • First Published: 25 October 2010